Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06138145 · ClinicalTrials.gov registry record · NA
Inclusion Appeal Videos and Intent to Register for Pediatric Clinical Trials
A NA study of Pediatric ALL and Patient Participation, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT06138145: Completed NA study of Pediatric ALL and Patient Participation, sponsored by University of Pennsylvania.
NCT06138145 is a NA study of Pediatric ALL and Patient Participation that has completed, run by University of Pennsylvania. The registered enrollment target is 125 participants, below the 1,642-participant average among 21 other Pediatric ALL trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06138145, a NA study of Pediatric ALL and Patient Participation, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
An informational video about joining a Research Notification Registry is being compared with a version of the video tailored to African/ African American parents, reminding them about the importance of their being included in clinical trials. African/African American parents and caregivers of children under 13 years of age are targeted.
Primary Outcome
Number of Participants with who made the decision to enroll in the CHOP pediatric clinical trials registry.
Conditions Studied
Interventions
- BEHAVIORAL Survey
- OTHER Video
Study Locations (1)
Pennsylvania
- CHOP Primary Care, Cobbs Creek - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2022-11-17 |
| Est. Completion | 2023-08-29 |
| Phase | NA |
What the finished NCT06138145 record still lists
NCT06138145 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,642-participant average among 21 other Pediatric ALL trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Pediatric ALL appearing as the primary indexed condition, and to 2 interventions - of which Survey is the first listed.
NCT06138145 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06138145 about?
NCT06138145 is a clinical study titled "Inclusion Appeal Videos and Intent to Register for Pediatric Clinical Trials". An informational video about joining a Research Notification Registry is being compared with a version of the video tailored to African/ African American parents, reminding them about the importance of their being included in clinical trials. African/African American parents and caregivers of childr...
What is the current status of trial NCT06138145?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2022-11-17. Estimated completion is 2023-08-29.
What conditions does trial NCT06138145 study?
This clinical trial studies the following conditions: Pediatric ALL, Patient Participation.
What interventions are being tested in trial NCT06138145?
The interventions under investigation include: Survey (BEHAVIORAL), Video (OTHER).
Who is sponsoring clinical trial NCT06138145?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06138145 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06138145's enrollment target sits among peer trials
125 9th of 21 higher than 13 of 21 other Pediatric ALL trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric ALL trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeS
RECRUITING · NA
-
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
HEalth Advocate for Liver Transplant - Pilot
RECRUITING · NA
-
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI